ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Design, synthesis, and biological studies of dual URAT1 inhibitor and FXR agonist based on benzbromarone

Huang, Wanqiu; Jiao, Shixuan; Chen, Siliang; Chen, Ya; Yang, Zhongcheng; Wang, Wenxin; Cao, Zhijun; Li, Zheng; Zhang, Luyong*广东药学院; 1
Bioorganic and Medicinal Chemistry2022-12-1DOI: 10.1016/j.bmc.2022.117073
7阅读
引用收藏
分享

摘要

With increased unhealthy dietary patterns and a sedentary lifestyle, the prevalence of hyperuricemia is growing rapidly, placing a tremendous burden on the public health system. Persistent hyperuricemia in extreme cases induces gout, gouty arthritis, and other metabolic diseases. Benzbromarone is a potent human urate transporter 1 (URAT1) inhibitor that is widely used as a uric acid-lowering drug. Recent studies indicated that benzbromarone can also activate farnesoid X receptor (FXR), whereas its agonistic activity on FXR is rather poor. Mounting evidence suggested that the etiology of gout is directly related to NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasomes, and FXR suppresses the expression of NLRP3 in various ways. Therefore, the dual URAT1 inhibitor and FXR agonist may exert synergistic effects on decreasing uric acid (UA) levels and inhibiting inflammation. To obtain a better dual URAT1 inhibitor and FXR agonist, we performed the structure-based drug design (SBDD) strategy to improve the FXR activation of benzbromarone by forming strong interactions with ARG331 in FXR binding pocket. All of these efforts lead to the identification of compound 4, which exerts better activity on FXR and uric acid-lowering effect than benzbromarone.

学科与关键词

关键词
URAT1FXRSBDDBenzbromarone
相关
加载中…
  • Design, Synthesis and Biological Activity of Low-Molecular-Weight URAT1 Inhibitors
    Chen, Siliang; Chen, Ya; Yang, Zhongcheng; Huang, Wanqiu; Cao, Zhijun; Wang, Xuekun; Yao, Huixin; Li, Zheng*; Wang, Guangji*ChemistrySelect, 2023, 8(5).
  • Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents
    Zhao, Zean; Liu, Jin; Yuan, Lin; Yang, Zichao; Kuang, Peihua; Liao, Hui; Luo, Jian; Feng, Huancun; Zheng, Fengxin; Chen, Yongjun; Wu, Ting; Guo, Jiayin; Cao, Ying; Yang, Yang; Lin, Cuiting; Zhang, Qun*; Chen, Jianjun*; Pang, Jianxin*European Journal of Medicinal Chemistry, 2022, 242: 114682.被引 3
  • Design, synthesis, and evaluation of the in vitro activity of novel dual inhibitors of XOR and URAT1 containing a benzoic acid group
    Zhu, Xin Ying; Chen, Hong Ming; Zhang, Lei; Qin, Yu Xiang; Li, Jing*Chemical Biology and Drug Design, 2023, 102(6): 1553-1567.
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic and Medicinal Chemistry
发表日期
2022-12-01
卷期
第 75 卷
页码
117073
DOI
10.1016/j.bmc.2022.117073
语言
ENGLISH
成果收录
SCIE
资助标注
Basic and Applied Basic Research of Guangzhou [202201010436]; National Key Clinical Specialty Construction Project; High -Level Clinical Key Specialty (Clinical Pharmacy) in Guangdong Province; Open Project of Guangxi Key Laboratory of Precision Medicine in Cardio [GXXNXG202101]; Special Fund of Science and Technology Innovation cultivation Project of Guangdong University students [pdjh2022a0262]; Innovation and Entrepreneurship Training program for College students [202110573005]

作者

  • H

    Huang, Wanqiu (第一作者)

    guangdong pharmaceut univ · new · 1

  • J

    Jiao, Shixuan

    guangdong pharmaceut univ · new · 1

查看全部 9 位作者收起作者
  • C

    Chen, Siliang

    guangdong pharmaceut univ

  • C

    Chen, Ya

    guangdong pharmaceut univ

  • Y

    Yang, Zhongcheng

    guangdong pharmaceut univ

  • W

    Wang, Wenxin

    guangdong pharmaceut univ

  • C

    Cao, Zhijun

    guangdong pharmaceut univ · new · 1

  • L

    Li, Zheng

    guangdong pharmaceut univ · new · 1

  • Z

    Zhang, Luyong (通讯)

    guangdong pharmaceut univ · new · china pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417